Company: KNRX
Filing Date: 2025-03-05
Form Type: F-1/A
Source: 0001493152-25-009104
Chunk: 77

Company: KNOREX LTD.
Filing Date: 2025-03-05
Form: F-1/A
Chunk 77
---
 Restructuring
Agreement, the Company also issued warrants to shareholders of the Company, who were previously shareholders of Knorex SG, and certain
other persons in exchange for warrants previously issued to them by Knorex SG. The warrants issued by the Company included: (i) a total
of 4,692,100 warrants with an aggregate amount of US$7,722,941 and (ii) a set of warrants with an aggregate amount of US$836,597, both
exercisable for the same type of securities the Company issues in its next immediate equity financing round that involves the issuance
of preference shares or preferred securities in the Company to raise funds for the Company (or Class A Ordinary Shares if such immediate
equity financing round is our Company’s initial public offering). In January 2025, a total of 164,713 warrants described in (i) above were exercised to subscribe for 164,713 Class A Ordinary Shares with the remaining 4,527,387 warrants having been cancelled in exchange for the issuance of a total of 4,527,387 warrants with an aggregate amount of US$7,073,397.74 to extend the expiration dates to a period range from March 2026 to December 2027.The expiration dates
of the warrants described in (ii)range from December
2024 to December 2026. The exercise price for the warrants described in (ii) above with an aggregate amount of US$836,597 shall be determined
by reference to the issue price of the types of securities and shall be equal to the issue price of the securities being offered in the
next immediate equity funding round (or equal to 65% of the issue price of Class A Ordinary Shares if the next immediate equity
funding round is the Company’s initial public offering), subject to adjustment for certain dilutive events such as, among other
things, subdivision, reclassification, redenomination, conversion or consolidation of securities, capitalization, capital distribution,
and rights issue. The maximum number of shares that each of these warrant holders may subscribe for shall be determined by dividing the
sum of the maximum subscription sum of the relevant warrant holder by the exercise price, as adjusted for dilutive event(s) where applicable,
corrected up to the nearest whole number. For details, see “Description of Share Capital—Warrants” in this prospectus.

The chart below illustrates our corporate structure as of the date of this prospectus:

| 41 |

<div align='